SUREGENE, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUREGENE, LLC.The latest application filed is for "genetic markers of antipsychotic response".

Company Profile

0.11.19

SUREGENE, LLC - Louisville KY US
SUREGENE, LLC - Jeffersontown KY
Suregene, LLC -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Genetic Markers Of Antipsychotic Response App 20160273042 - RAMSEY; Timothy ; et al.	2016-09-22
Genetic Markers Of Mental Illness App 20160168637 - Brennan; Mark David ; et al.	2016-06-16
Genetic Markers Of Antipsychotic Response App 20160122821 - LIU; Qian ; et al.	2016-05-05
Genetic Markers Of Mental Illness App 20150167086 - Brennan; Mark David ; et al.	2015-06-18
Genetic markers of mental illness Grant 9,040,241 - Brennan , et al. May 26, 2	2015-05-26
Genetic Markers for Optimizing Treatment for Schizophrenia App 20140350000 - Brennan; Mark David ; et al.	2014-11-27
Genetic Markers Of Mental Illness App 20140288054 - Brennan; Mark David ; et al.	2014-09-25
Genetic markers of mental illness Grant 8,586,308 - Brennan , et al. November 19, 2	2013-11-19
Genetic markers for schizophrenia and bipolar disorder Grant 8,460,868 - Brennan June 11, 2	2013-06-11
Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature App 20130090329 - Ramsey; Timothy L. ; et al.	2013-04-11
Methods And Compositions For The Treatment Of Psychotic Disorders Through The Identification Of The Sult4a1-1 Haplotype App 20120277211 - Ramsey; Timothy L. ; et al.	2012-11-01
Genetic Markers for Assessing Risk of Developing Bipolar Disorder App 20120129171 - Brennan; Mark David ; et al.	2012-05-24
Methods And Compositions For The Treatment Of Psychotic Disorders Through The Identification Of The Olanzapine Poor Response Predictor Gene Signature App 20120094854 - Ramsey; Timothy L. ; et al.	2012-04-19
Genetic markers for assessing risk of developing bipolar disorder Grant 8,129,117 - Brennan , et al. March 6, 2	2012-03-06
Genetic markers of schizophrenia endophenotypes Grant 8,114,600 - Brennan , et al. February 14, 2	2012-02-14
Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Grant 7,985,551 - Ramsey , et al. July 26, 2	2011-07-26
Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Grant 7,972,793 - Ramsey , et al. July 5, 2	2011-07-05
Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Grant 7,951,543 - Ramsey , et al. May 31, 2	2011-05-31
Methods And Compositions For The Treatment Of Psychotic Disorders Through The Identification Of The Sult4a1-1 Haplotype App 20110105468 - Ramsey; Timothy L. ; et al.	2011-05-05
Methods And Compositions For The Treatment Of Psychotic Disorders Through The Identification Of The Sult4a1-1 Haplotype App 20110105467 - RAMSEY; TIMOTHY L. ; et al.	2011-05-05
Methods And Compositions For The Treatment Of Psychotic Disorders Through The Identification Of The Sult4a1-1 Haplotype App 20110105469 - Ramsey; Timothy L. ; et al.	2011-05-05
Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature Grant 7,932,042 - Ramsey , et al. April 26, 2	2011-04-26
Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype Grant 7,790,396 - Ramsey , et al. September 7, 2	2010-09-07
Genetic Markers of Schizophrenia Endophenotypes App 20100119625 - Brennan; Mark David ; et al.	2010-05-13
Genetic Markers for Assessing Risk of Developing Schizophrenia App 20100119626 - Ramsey; Timothy Lynn ; et al.	2010-05-13
Genetic Markers for Assessing Risk of Developing Bipolar Disorder App 20100120046 - Brennan; Mark David ; et al.	2010-05-13
Genetic Markers for Optimizing Treatment for Schizophrenia App 20100105062 - Brennan; Mark David ; et al.	2010-04-29

Company Registrations

NCAGE Code	47J30	SUREGENE LLC!DBA SUREGENE
CAGE Code	47J30	SUREGENE LLC SUREGENE
SEC	0001464115	SureGene LLC of KENTUCKY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.